0001437749-23-031986.txt : 20231114 0001437749-23-031986.hdr.sgml : 20231114 20231114161924 ACCESSION NUMBER: 0001437749-23-031986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231113 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Purav CENTRAL INDEX KEY: 0001818246 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38634 FILM NUMBER: 231406645 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD., SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REVIVA PHARMACEUTICALS HOLDINGS, INC. CENTRAL INDEX KEY: 0001742927 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 4085018881 MAIL ADDRESS: STREET 1: 19925 STEVENS CREEK BLVD. STREET 2: SUITE 100 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: Tenzing Acquisition Corp. DATE OF NAME CHANGE: 20180606 4 1 rdgdoc.xml FORM 4 X0508 4 2023-11-13 0001742927 REVIVA PHARMACEUTICALS HOLDINGS, INC. RVPH 0001818246 Patel Purav C/O REVIVA PHARMACEUTICALS HOLDINGS, INC 19925 STEVENS CREEK BLVD, SUITE 100 CUPERTINO CA 95014 1 0 Stock Option (right to buy) 6.04 2023-11-13 4 A 0 8200 0 A 2033-11-12 Common Stock, par value $0.0001 per share 8200 8200 D The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of one hundred percent (100%) of the shares subject thereto upon the one year anniversary of the date of grant, provided that Awardee remains a director of the Company through such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan. /s/ Narayan Prabhu, attorney-in-fact for Purav Patel 2023-11-14